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Abstract
Background/Aim. Oxidative stress plays a critical role in
the pathogenesis of various diseases. Recent reports indicate
that obesity may induce systemic oxidative stress. The aim of
the study was to potentiate oxidative stress as a factor which
may aggravate peripheral insulin sensitivity and insulin-
secretory response in obesity in this way to potentiate devel-
opment of diabetes. The aim of the study was also to estab-
lish whether insulin-secretory response after glucagon-
stimulated insulin secretion is susceptible to prooxi-
dant/antioxidant homeostasis status, as well as to determine
the extent of these changes. Methods.  A mathematical
model of glucose/insulin interactions and C-peptide was used
to indicate the degree of insulin resistance and to assess their
possible relationship with altered antioxidant/prooxidant
homeostasis. The study included 24 obese healthy and 16
obese newly diagnozed non-insulin dependent diabetic pa-
tients (NIDDM) as well as 20 control healthy subjects,
matched in age. Results. Total plasma antioxidative capacity,
erythrocyte and plasma reduced glutathione level were signifi-
cantly decreased in obese diabetic patients, but also in obese
healthy subjects, compared to the values in controls. The
plasma lipid peroxidation products and protein carbonyl
groups were significantly higher in obese diabetics, more than
in obese healthy subjects, compared to the control healthy
subjects. The increase of erythrocyte lipid peroxidation at basal
state was shown to be more pronounced in obese daibetics, but
the apparent difference was obtained in both the obese healthy
subjects and obese diabetics, compared to the control values,
after exposing of erythrocytes to oxidative stress induced by
H2O2. Positive correlation was found between the malondial-
dehyde (MDA) level and index of insulin sensitivity (FIRI).
Conclusion. Increased oxidative stress together with the de-
creased antioxidative defence seems to contribute to de-
creased insulin sensitivity and impaired insulin secretory re-
sponse in obese diabetics, and may be hypothesized to favour
the development of diabetes during obesity.
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Apstrakt
Uvod/Cilj. Oksidativni stres igra važnu ulogu u patogenezi
raznih bolesti. Najnovija saopštenja ukazuju da gojaznost
može izazvati sistemski oksidativni stres. Cilj ovog rada bio je
da se ukaže na važnost oksidativnog stresa kao faktora koji
može negativno da utiče na perifernu insulinsku osetljivost i
insulinsku sekretornu reakciju kod gojaznosti i na taj način
izazove razvoj dijabetesa. Cilj rada takođe je bio i da se utvrdi
da li je insulinska sekretorna reakcija posle glukagon-
stimulisane insulinske sekrecije osetljiva na prooksida-
tivni/antoksidativni status homeostaze i da se odredi obim
promena.  Metode.  Matematički model interakcija glu-
koza/insulin i C-peptida uzet je kao pokazatelj stepena insu-
linske rezistencije i utvrđivanja njihove moguće veze sa iz-
menjenom antioksidativnom/prooksidativnom homeo-
stazom. Studija je obuhvatala 24 gojazne zdrave osobe i 16
gojaznih sa novopostavljenom dijagnozom insulin-nezavisnog
dijabetesa (NIDDM), kao i 20 zdravih osoba kontrolne grupe
usklađenih po starosti. Rezultati.  Značajno su bili sniženi
ukupni plazma antioksidativni kapacitet i redukovani nivoi
glutationa eritrocita i plazme kod gojaznih bolesnika sa dija-
betesom, ali i kod zdravih gojaznih osoba u poređenju sa
kontrolnom grupom. Proizvodi lipidne peroksidacije i kar-
bonilne grupe proteina u plazmi bili su značajno viši kod go-
jaznih sa dijabetesom nego kod zdravih gojaznih osoba u
poređenju sa kontrolnom grupom zdravih osoba. Porast lip-
idne peroksidacije eritrocita u bazalnom stanju bio je izraženiji
kod gojaznih sa dijabetesom, ali je uočljiva razlika postojala i
u grupi gojaznih zdravih osoba u poređenju sa vrednostima u
kontrolnoj grupi posle izlaganja eritrocita oksidativnom stresu
indukovanom pomoću H2O2. Nađena je pozitivna korelacija
između nivoa malondialdehida (MDA) i indeksa insulinske
osetljivosti (FIRI). Zaključak. Povišeni oksidativni stres za-
jedno sa sniženom antioksidativnom zaštitom izgleda da dopri-
nosi sniženju insulinske osetljivosti i insulinske sekretorne reak-
cije kod gojaznih bolesnika sa dijabetesom, te se može pret-
postaviti da ubrzava razvoj dijabetesa kod gojaznih osoba.
Ključne reči:
stres, oksidativni; dijabetes melitus, insulin-nezavisni;
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Introduction
Oxidative stress plays a critical role in the pathogenesis
of
 various diseases 
1. Recent reports indicate that obesity may
induce
 systemic oxidative stress 
2. Increased free radical pro-
duction in accumulated fat, because of increased nicotinanide
adenine dinucleotide phosphate (NADPH) oxidase and de-
creased antioxidant
  enzymes activity, causes dysregulated
production of adipocytokines locally, such as plasminogen
activator inhibitor–1 (PAI-1), tumor necrosis factor α (TNF-
α), resistin, leptin and adiponectin 
3−8.
  Increased oxidative
stress in blood can affect other
 organs such as endothelium,
liver and skeletal muscle, and may lead to decreased insulin
sensitivity and development of insulin
  resistance in obese
subjects 
8−10.
In diabetes, oxidative
 stress impairs glucose uptake in
muscle and fat and
 decreases insulin secretion from pancre-
atic β cells
 11−13. Increased oxidative stress also underlies the
pathophysiology
  of late diabetic complications directly af-
fecting
 vascular wall 
14.
The life time risk to develop impaired glucose tolerance
and diabetes is increased among obese subjects compared to
normal-weight matched subjects 
15, 16. Complex interactions
between obesity and insulin resistance largely account for the
pathogenesis of non-insulin dependent diabetes. There are
many factors that can aggravate insulin resistance of obesity.
Elevated insulin level itself is atherogenic by stimulating
sympathetic nerve activity. Increased insulin secretion is as-
sociated with the progressive loss of β-cell function as well.
Insulin resistance results in reduced peripheral disposal of
glucose in muscle and increased hepatic glucose output in
the fasting state 
17, 18. Decreased concentration of reduced
thiols together with increased lipid peroxidation products,
may play a role in the development of insulin resistance, be-
cause an optimal antioxidant/prooxidant state is required for
the stabilization of nitric oxide available for insulin ac-
tion 
19, 20.
The study was performed with the aim to estimate
the relation between susceptibility to oxidative stress and
the antioxidative defense system as possible risk factors
of importance in the development of diabetes during obe-
sity; to establish whether insulin-secretory response was
susceptible to prooxidant/antioxidant status of the homeo-
stasis, the extent of their changes in the course of stimu-
lated insulin secretion was performed. A mathematical
model of glucose/insulin interactions was used to indicate
the degree of insulin resistance and to asses the possible
relationship with the altered antioxidant/prooxidant ho-
meostasis.
Methods
The study included 24 obese healthy and 16 obese
newly diagnozed non-insulin dependent diabetic patients
(NIDDM), as well as 20 control healthy subjects, blood do-
nor volunteers, matched in age. The degree of obesity was
defined in terms of body mass index−BMI (kg/m
2). Patients
and control subjects taking antioxidative vitamins or other
drugs with antioxidative properties were excluded from the
study.
Heparinized venous blood was obtained by peripheral
venopuncture. The first blood sample was always collected
at 8.00 am after 12 h of fasting, the second was collected
after the glucagon test. All samples were immediately
centrifuged at 2  000g for 15 min, plasma was carefully
removed. Sedimented erythrocytes were washed three
times in physiological saline. Received plasma and eryth-
rocytes were immediately processed for the analyses de-
scribed below.
All chemicals were of analytical grade purity, including
5.5 dithiobis nitrobensoic acid – DTNB, thiobarbituric acid –
TBA and xanthine (ICN Biochemicals, Costa Mesa, CA
USA and Serva).
Residual β-cell function was assessed by using the in-
travenous glucagon stimulation test. Obese subjects and
obese diabetics received 1mg intravenously (i.v.) glucagon
and blood samples were collected at basal state (0 min) and 6
min after. The values for the residual β-cell function was as-
sessed from the insulin and glucose concentrations by the
formula 
21:
β-cell function (%) = 20 × insulin/glucose-3.5 (before
and after the glucagon stimulation).
Insulin resistance was expreassed as an empirical fast-
ing insulin resistance index (FIRI) consisting of the product
of plasma insulin and glucose that was obtained by the for-
mula 
22:
FIRI = fasting glucose × fasting insulin/25 (normally
around 1 unit).
The reduced glutathione level (GSH) in plasma was
measured by spectrophotometric assay using DTNB 
23. The
level of plasma GSH was expressed as μmol/l.
The packed erythrocytes (0.2 ml) were treated with the
same volume of ice-cold H2O and 1.3 ml of 5% TCA-1.0
mM EDTA immediately after the drawing. The supernatant
was analyzed for sulphydryl group content at 412 nm with
DTNB in 0.1 M phosphate buffer
 23. The level of erythrocyte
reduced glutathione (RBC GSH) was expressed as μmol/ml
RBC.
Plasma antioxidative capacity was tested by the modifi-
cation of procedure of Asakawa and Matsushita 
24 using an
in vitro model of Fe
2+-induced peroxidation of liposome sus-
pension (from egg yolks). For this purpose 1.5 ml of lipo-
some suspension at the concentration of 0.5 mg of total egg
yolk phospholipids/ml, 0.2 ml of 0.5 M phosphate buffer pH
7.4 and 0.3 ml of tested plasma sample were incubated at
37 
oC for 30 min by adding 0.2 ml of 1 mM/l FeCl2. Then 1
ml of 30% TCA was added to the reaction mixture followed
by centrifugation for 15 min at 10 000 g. One milliliter of
0.67% TBA was added to 1ml of the received supernatant
and the mixture was boiled at 97 
oC for 20 min. Optical ab-
sorbance was measured at 532 nm. In this way, under pro-
oxidant conditions (in the presence of traces of iron) incuba-
tion was carried out and the capacity of plasma to scavenge
free oxygen radical production was determined as malon-
dialdehyde (MDA) level. The antioxidative capacity was ex-
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pared with the control samples which contained phosphate
buffer instead of plasma.
Plasma lipid peroxidation was determined by thiobar-
bituric acid (TBA) reactivity. A colored complex has a
maximum absorbance at 532 nm. The level of MDA was ex-
pressed as μmol/l. The activity of xanthine oxidase was de-
termined by the increase of uric acid production when xan-
thine was used as substrate 
25.
The level of lipid peroxidation products in erythrocytes
was estimated by measuring TBA reactivity 
26. For this pur-
pose 0.4 ml of packed cells were suspended in 1.6 ml of
phosphate buffer saline pH 7.4 (as a 20% suspension of red
cells). To this suspension 0.5 ml of 30% TCA was added and
2 ml of the obtained supernatant was transferred into another
tube, and 0.15 ml of 0.1 M/l EDTA and 0.5 ml of 1% TBA
(dissolved in 0.05 M NaOH) was added. Tubes were mixed
and kept in a boiling water for 15 minutes. After thad the
tubes were cooled to room temperature, absorbance was read
at 532 nm and 600 nm. Absorbance at 600 nm was sub-
stracted from absorbance at 532 nm. Malondialdehyde values
in nmol/ml of erythrocytes (RBC) were determined using the
extinction coefficient of MDA/TBA complex at 532 nm
(1.56 × 10
5 per cm per molar solution). The results were ex-
pressed as nmol MDA/ml RBC.
For estimation of erythrocyte susceptibility to H2O2 in-
duced oxidative stress, erythrocytes were washed with an
isotonic saline solution containing 2.0 mM sodium azide to
inhibit catalase activity
 26. Washed erythrocytes were resus-
pended in saline-azide potassium phosphate buffer pH 7.4.
One mililiter of 20% cell suspension was then preincubated
for 10 min at 37 
oC. Peroxidative challenge was induced by
addition of an equal volume (1.0 ml) of H2O2 in isotonic sa-
line-azide solution (final H2O2 concentration 3.0 mM). The
reaction was terminated by the addition of 0.5 ml of 30%
TCA and mixture was centrifuged. Malondialdehyde was
detected in the obtained supernatant as a basic TBA reacting
agent and it was used as an indicator of lipid peroxidation.
The obtained results were expressed as nmolMDA/ml RBC.
Protein carbonyls were measured in plasma proteins
and the remaining protein pellet according to the method ex-
plained in our previous report 
27.
Heparinised blood samples were collected for the assay
procedures. After preparing the hemolysate, where the labile
fraction is eliminated, hemoglobins are retained by cationic
exchange resin and chromatographic (ion exchange)-
spectrophotometric method was used for the measurement of
hemoglobin A1c (BioSystems). Plasma fructosamine was
measured by the method of Bake et al 
28.
Plasma glucose was monitored by an ILAB 300 ana-
lyzer.
Plasma C-peptide and insulin were assayed by using the
radioimmunoassay kits (Inep- Vinca-Serbia).
All presented values were given as mean + SD for sta-
tistical evaluation of the results between two groups. For
multiple comparisons of means the ANOVA analysis of
variance was used. The coefficient of the correlation (r) be-
tween the investigated parameters was obtained by the linear
regression analysis and by the regression equation.
Results
The clinical characteristics of 24 obese healthy subjects
and 16 obese − newly diagnosed diabetics, at the time of the
study, are shown in Table 1. The mean age of obese subjects
was 48.52±6.4 yr (mean ±SD; range 36−61 yr) and of
obese diabetics 50.3±6.2 yr (range 42−61 yr). There was a
predominance of female (n = 17) over male obese subjects
(n = 7) and of obese diabetics 9 were male and 7 female.
Plasma HbA1c and fructosamine level were significantly
higher in obese diabetics compared with the level in obese
healthy subjects. Significant difference was found between
functional activity of β-cells (expressed as percents of C-
peptide secretion during normal function). The obtained re-
sults point to significantly reduced residual β-cell function
in obese diabetics at basal state and after glucagon load
(Figures 1 and 2).
Significantly lower total plasma antioxidative capacity
was found in both groups of the obese diabetics and the
obese healthy subjects compared with the control values
(Figure 3). The values of total plasma antioxidative capacity,
as well as plasma and erythrocyte GSH (glutathione) con-
centration progessively decreased from obese healthy sub-
Table 1
Main clinical characteristics of obese healthy subjects and obese recent-onset non-
insulin dependent diabetes mellitus (NIDDM) patients
Variables
Obese healthy
subjects
mean ±SD
Obese NIDDM
patients
mean ±SD
Control subjects
mean ±SD
Number of patients 24 16 20
Sex (male/female) 7/17 9/7 12/8
Age (yr) 48.52±6.4 52.3±6.7 44.33±5.3
Body mass index (kg/m
2) 34.33±4.2* 33.1±5.1* 25.32±4.34
Duration of diabetes (months) − 7.8±5.4 −
Plasma fructosamine
(U/g proteins) 0.44±0.1 0.72±0.2* 0.39±0.07
Plasma hemoglobin A1c (g/l) 4.3±0.7 11.9±4.0 4.0±1.1
Fasting plasma glucose (mmol/l) 4.8±0.8 12.3±3.6* 4.2±0.5
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jects to obese diabetics (Figures 3 and 4). The level of
plasma proten oxidative modification products-protein car-
bonyls was significantly increased in both groups compared
to controls (Figure 4). Plasma MDA level of obese diabetics
had the highest value, but in obese healthy subjects it was
also increased compared with the control values. Statistically
significant increase in the concentrations of erythrocyte MDA
products was found in obese diabetics and obese healthy sub-
jects compared to control healthy subjects. The changes in
erythrocyte MDA concentration after H2O2 - induced oxidative
stress, which are also documented in Figure 5, indicate that the
cells of obese diabetics are the most susceptible ones to oxida-
tive stress. The activity of xanthine oxidase was significantly
increased in obese subjects but in obese NIDDM it was al-
most twice as of the control (Figure 6). The level of plasma
MDA positivelly correlated with FIRI, indicating that in-
creased oxidative stress may contribute to increased insulin
resistance (Figure 7).
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Fig. 5 − Plasma and erythrocyte (RBC) MDA at basal state
(I) and after H2O2-induced oxidative stress (II)
Plasma lipid peroxidation was determined by thiobarbituric acid
(TBA) reactivity 
25. The level of MDA was expressed as  μmol/l. The
level of  lipid peroxidation products in erythrocytes was estimated
by measuring thyobarbituric acid (TBA) reactivity 
26. For the esti-
mation of erythrocyte susceptibility to H2O2-induced oxidative
stress, the peroxidative challenge was induced by addition of an
equal volume (1.0 ml) of  H2O2 in isotonic saline-azide solution (final
H2O2 concentration 3.0 mM). Results were expressed as  nmol
MDA/ml RBC
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Fig. 4 − Plasma total antioxidative capacity (AOC) and
plasma carbonyl group (CG) content of investigated groups
(percent of basal value)
Plasma antioxidative capacity was tested by the modification of
procedure of Asakawa  and Matsushita 
24 using an in vitro model of
Fe
2+-induced peroxidation of liposome suspension (from egg yolks).
Protein carbonyls was measured in plasma proteins according to the
method explained in our previous report 
27
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Fig. 1 − Fasting and glucagon-stimulated C-peptide in obese
healthy subjects and diabetic patients
Obese subjects and obese diabetics received 1mg iv glucagon and
blood samples were collected at basal state (0 min) and 6 min after.
C-peptide was measured in both samples
Obese healthy subjects Obese diabetic patients
0
100
200
300
400
500
600
p < 0.001
p < 0.001
%
Fig. 2 − Beta-cell functional activity after glucagon load
(percent of basal value)
Residual β-cell function was assessed by using the intravenous
glucagon stimulation test. The values for the residual β-cell function
were assessed from the insulin (light box) and glucose (dark box)
concentrations by mathematical formula 
21
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Fig. 3 − Plasma and erythrocyte (RBC) GSH in investigated
groups
Reduced glutathione level (GSH) in plasma was measured by
spectrophotometric assay using DTNB 
23. The level of plasma GSH
was expressed as μmol/l. The level of RBC GSH was expressed as
μmol/ml RBCVolumen 64, Broj 6 VOJNOSANITETSKI PREGLED Strana 395
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Fig. 6 − Xanthine oxidase activity in plasma of
investigated subjects
The activity of xanthine oxidase (U/l) was measured according to the
measurement of uric acid liberation
y = 1.0125x - 2.1665
R
2 = 0.6541
R=0.80
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Fig. 7 − Correlation between MDA and FIRI
The coefficient of the correlation (R) between malondialdehyde
(MDA) and index of fasting insulin resistence (FIRI) was  obtained
by linear regression analysis  and by regression equation
Discussion
The accumulation of fat and BMI closely correlates
with the
 markers of systemic oxidative stress 
2, 29, 30. It was
documented that the adipose tissue represents a major source
of the elevated
 plasma free radicals in obesity, because of the
increased NADPH oxidase activity and elevated level
 of fatty
acids.
 A high level of mRNA expression of the transcription
factor PU.1, which upregulates the transcription of the
NADPH
 oxidase gene in adipose tissue of obese mice was
documented 
30. Byproducts of lipid peroxidation, such as
trans-4-hydroxy-2-nonenal and malondialdehyde, are docu-
mented as potent chemoattractants, which may cause the
 in-
filtration of macrophages and inflammation in adipose
 tissue
during obesity 
2, 31−33. They may be the important
 source of
inflammatory cytokines, are also
 known to produce free radi-
cals via NADPH oxidase 
33, 34. In the present study, it was
documented that obesity may serve as an independent risk
factor for the decreased activities of antioxidants and for the
associated susceptibility to systemic oxidative stress. The
generation of reactive oxygen species has been suggested to
occur via xanthine oxidase activity as well.
Plasma and cellular level of antioxidant defense sys-
tem represents an antioxidant endogenous potential that can
protect cells from the toxic effects of free radicals. Fall in
antioxidant plasma and cellular defense (plasma antioxida-
tive capacity, plasma GSH as well as RBC GSH) was the
most obvious in obese diabetics (Figures 3 and 4). A possi-
ble reason for the decreased level in obese subjects and
obese diabetics may be related to decreased glutathione re-
ductase activity, decreased GSH synthesis by glutathione-
synthetase,  γ-glutamyl-cysteine synthetase, glutathione-S-
transferase and the impaired transport of thiol compounds
in erythrocytes 
35−39. The exogenous GSH can potentiate
and modulate glucose-induced insulin secretion from rat
pancreatic islets in a dose-related manner. Reduced plasma
antioxidative activity which was found in obese subjects
and especially obese diabetics, could be also due to the
structural modifications, such as glycosylation, of antioxi-
dative enzymes 
40.
Recent results have indicated that a local increase in
oxidative
 stress in accumulated fat causes dysregulated pro-
duction of
  adipocytokines. It was
  also shown that nuclear
translocation of PPARγ was inhibited
  in conditions of in-
creased generation of free radicals 
41, 42. Therefore,
  down-
regulation of adiponectin expression may be partially attrib-
uted
 to the decreased gene expression and smaller amount of
nuclear
 PPARγ under increased oxidative stress. Oxidative
stress is known to impair both insulin
 secretion by pancreatic
β cells 
13 and glucose transport
 in muscle and adipose tissue
11, 12. The reactive oxygen species (ROS), such
 as H2O2, are
produced transiently in the response to insulin stimulation
and also act as a second messenger for insulin signaling in
adipocytes via NADPH oxidase 
43−45. A transient increase of
intracellular ROS is important for the
 insulin signaling path-
way, while excessive and long term exposure
 to ROS reduces
insulin sensitivity and impairs glucose and lipid
 metabolism.
An increased oxidative stress is capable of decreasing insulin
sensitivity and peripheral insulin effectivity. Insulin is effec-
tive through the increased nitric oxide (NO) production, but
in the presence of free oxygen radicals the activating system
NO-guanylate cyclase-c-GMP may have impaired functional
activity 
46. The results which are summarized in Figure 7 in-
dicate that the increased oxidative stress positively correlated
with FIRI. The erythrocytes of obese diabetics are more sus-
ceptible to lipid peroxidation with a free radical initiator than
the erythrocytes of obese healthy subjects or the controls
(Figure 5). Newly diagnosed NIDDM patients showed the
more pronounced increase of circulating level of MDA in
plasma and erythrocytes compared with obese healthy sub-
jects or the control subjects. The results of the San Antonio
Heart Study 
47 demonstrated that hyperglycaemia itself can
cause the increased oxidative stress and susceptibility to oxi-
dation of macromolecules, including plasma lipids and pro-
teins.  Abnormalities in membrane function, including the
decrease of insulin receptors and glucose transport have been
already shown to exist in experimental and human obesity
and diabetes, but together with the enhanced production of
free oxygen radicals, they are able to damage cell membrane
systems leading to the mechanical disruption and increased
permeability 
37, 48. Enhanced production of free oxygen radi-
cals could cause the damage of cells leading to the decreased
secretory potential of islet cells, because they have very low
free radical scavenging enzyme activities 
48. Xanthine oxi-
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metabolism, representing at the same time a central mecha-
nism of oxidative tissue injury through the production of su-
peroxide anion radical. Its activity is significantly increased
in obese healthy subjects and obese NIDDM patients (Fig-
ure 6).
Our previous results indicated that more aggressive in-
sulin-sensitizing therapy is the therapy of choice in reducing
oxidative stress in non-insulin-dependent diabetes 
49. The re-
sults of the present study may confirm current suggestions
that insulin-sensitizing therapy, given together with antioxi-
dants, may delay the onset and/or development of non-
insulin dependent diabetes during obesity 
50.
Conclusion
The disbalance between free radical-induced increase in
lipid and protein oxidative modification, together with the
decreased antioxidant plasma and cellular defences, may ag-
gravate insulin resistance and decrease insulin-secretory re-
sponse in obese subjects.
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